DUSKEY, JASON THOMAS
 Distribuzione geografica
Continente #
NA - Nord America 5.903
EU - Europa 4.211
AS - Asia 3.192
SA - Sud America 405
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 73
OC - Oceania 9
Totale 13.900
Nazione #
US - Stati Uniti d'America 5.759
SE - Svezia 1.936
IT - Italia 1.086
SG - Singapore 995
CN - Cina 808
GB - Regno Unito 361
HK - Hong Kong 358
VN - Vietnam 355
BR - Brasile 302
BD - Bangladesh 191
DE - Germania 159
RU - Federazione Russa 139
FI - Finlandia 125
FR - Francia 110
KR - Corea 89
CA - Canada 80
ID - Indonesia 67
IN - India 67
NL - Olanda 51
JP - Giappone 43
AR - Argentina 39
TR - Turchia 39
BG - Bulgaria 37
MY - Malesia 29
UA - Ucraina 27
LT - Lituania 26
PK - Pakistan 25
MX - Messico 24
ZA - Sudafrica 22
ES - Italia 21
IQ - Iraq 21
IE - Irlanda 20
PL - Polonia 20
CH - Svizzera 15
VE - Venezuela 15
BE - Belgio 14
CO - Colombia 13
EC - Ecuador 13
AE - Emirati Arabi Uniti 12
PH - Filippine 12
RO - Romania 12
AT - Austria 11
CR - Costa Rica 11
TN - Tunisia 11
TH - Thailandia 10
IL - Israele 9
JM - Giamaica 9
MA - Marocco 9
AU - Australia 7
CL - Cile 7
DK - Danimarca 7
NP - Nepal 7
PY - Paraguay 7
TW - Taiwan 7
UZ - Uzbekistan 7
GR - Grecia 6
PT - Portogallo 6
DZ - Algeria 5
ET - Etiopia 5
SA - Arabia Saudita 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
EE - Estonia 4
EG - Egitto 4
GT - Guatemala 4
KE - Kenya 4
QA - Qatar 4
AM - Armenia 3
GE - Georgia 3
IR - Iran 3
KG - Kirghizistan 3
LY - Libia 3
PE - Perù 3
PR - Porto Rico 3
AN - Antille olandesi 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
SC - Seychelles 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CU - Cuba 1
CY - Cipro 1
GY - Guiana 1
Totale 13.777
Città #
Stockholm 1.778
Ashburn 787
Santa Clara 638
Singapore 624
San Jose 426
Fairfield 365
Hong Kong 347
Chandler 286
Hefei 276
Council Bluffs 267
Woodbridge 166
Seattle 150
Houston 145
Modena 144
Cambridge 142
Los Angeles 136
London 134
Southend 132
Wilmington 128
Beijing 126
Nyköping 125
New York 124
Chicago 115
Ho Chi Minh City 112
Helsinki 101
Dallas 98
Bologna 92
Seoul 86
Hanoi 85
The Dalles 68
Milan 62
Munich 58
Lauterbourg 53
Shanghai 53
Jakarta 52
San Diego 43
Reggio Emilia 41
Boardman 40
Rome 39
Ann Arbor 38
Moscow 38
Buffalo 33
Princeton 33
Sofia 33
Falls Church 31
Phoenix 31
São Paulo 29
Frankfurt am Main 28
Brooklyn 26
Tokyo 24
Montreal 22
Salt Lake City 22
Orem 21
Atlanta 20
Da Nang 19
Dearborn 19
Iowa City 19
Jacksonville 18
Parma 18
Florence 17
Warsaw 17
Washington 17
Turku 16
Denver 15
Johannesburg 15
Kent 15
Tampa 15
Amsterdam 14
Castrezzato 14
Des Moines 14
Dublin 14
Elk Grove Village 14
Haiphong 14
Nuremberg 14
Guangzhou 13
Dong Ket 12
Redondo Beach 12
Toronto 12
Turin 12
Wuhan 12
Ankara 11
Catania 11
Izmir 11
Miano 11
Mumbai 11
Naples 11
Redwood City 11
Boston 10
Brussels 10
Düsseldorf 10
Eugene 10
Mexico City 10
Portsmouth 10
Rio de Janeiro 10
Saint Augustine 10
Shenzhen 10
Columbus 9
Baghdad 8
Chennai 8
Lakewood 8
Totale 9.664
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.063
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 378
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 351
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 350
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 342
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 341
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 311
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 302
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 301
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 296
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 294
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 294
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 293
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 285
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 282
Challenges of enzyme therapy: Why two players are better than one 275
Microfluidic technology for the production of hybrid nanomedicines 273
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment 269
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 261
Tween® preserves enzyme activity and stability in PLGA nanoparticles 255
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor 248
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 247
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization 238
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function 237
Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier 231
Analysis of Molecular Parameters Determining the Antimalarial Activity of Polymer-Based Nanomimics 228
Tunneling Nanotubes: A New Target for Nanomedicine? 227
Nanoparticle ligand presentation for targeting solid tumors 222
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments 219
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 214
Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application? 211
Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology 208
Development and biocompatibility assessments of poly(3-hydroxybutyrate-co-ε-caprolactone) microparticles for diclofenac sodium delivery 207
Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver 206
Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs 205
An overview of current drug delivery strategies for glioblastoma treatment and barriers to progress 205
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy 203
Engineered non-toxic cationic nanocarriers with photo-triggered slow-release properties 198
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 194
Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery 185
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges 184
Chaperonin–Dendrimer Conjugates for siRNA Delivery 181
PH-responsive PDMS-b-PDMAEMA micelles for intracellular anticancer drug delivery 171
New concepts to fight oxidative stress: Nanosized three-dimensional supramolecular antioxidant assemblies 165
Miniaturization of gene transfection assays in 384- and 1536-well microplates 165
Quantitative comparison of the protein corona of nanoparticles with different matrices 164
The uptake mechanism of PEGylated DNA polyplexes by the liver influences gene expression 160
Nanomedicines for brain diseases: Where we are and where we are going 152
PH-Triggered Reversible Multiple Protein-Polymer Conjugation Based on Molecular Recognition 146
Stimuli-Responsive Codelivery of Oligonucleotides and Drugs by Self-Assembled Peptide Nanoparticles 138
Drug delivery systems for mitochondrial targeting 125
Totale 13.900
Categoria #
all - tutte 54.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022596 0 0 0 39 58 54 36 53 102 69 97 88
2022/2023797 94 80 56 77 79 108 24 85 98 19 41 36
2023/2024699 31 60 46 57 123 93 42 81 18 34 22 92
2024/20252.530 87 43 63 161 448 326 208 164 286 114 263 367
2025/20266.387 328 195 370 473 522 264 541 287 2.302 416 294 395
2026/20271.248 158 289 352 449 0 0 0 0 0 0 0 0
Totale 13.900